Veradigm (NASDAQ:MDRX) Stock Price Up 6.3% – Time to Buy?

Shares of Veradigm Inc. (NASDAQ:MDRX) were up 6.3% during trading on Friday . The company traded as high as $5.10 and last traded at $5.10. Approximately 378 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 184,325 shares. The stock had previously closed at $4.80.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised Veradigm to a “hold” rating in a research note on Saturday, March 7th.

Veradigm Price Performance

The firm has a market cap of $565.88 million, a PE ratio of 23.25 and a beta of 0.52. The firm has a 50-day simple moving average of $4.52 and a 200 day simple moving average of $4.65.

Veradigm Company Profile

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.